Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod

Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod

Jorge Correale,1 Erwin Chiquete,2 Snezana Milojevic,3 Nadina Frider,3 Imre Bajusz31Raúl Carrea Institute for Neurological Research, Foundation for the Fight against Infant Neurological Illnesses, Buenos Aires, Argentina; 2Department of Neurology and Psychiatry, Salvador Zubirá...

Full description

Bibliographic Details
Main Authors: Correale J, Chiquete E, Milojevic S, Frider N, Bajusz I
Format: Article
Language:English
Published: Dove Medical Press 2014-06-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/assessing-the-potential-impact-of-non-proprietary-drug-copies-on-quali-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/assessing-the-potential-impact-of-non-proprietary-drug-copies-on-quali-peer-reviewed-article-DDDT

Similar Items